A drug called brentuximab may help patients with advanced lymphogranulomatosis. In Russia, thousands of people are fighting this serious illness.
Many thousands of Russians who find out they have late-stage lymphogranulomatosis may benefit from a drug called brentuximab, which has the ability to seek out and destroy tumor cells. A study by scientists from Manchester showed that brentuximab is a more effective treatment option than traditional chemotherapy. And in the near future, as expected, this medicine will be officially licensed for the treatment of lymphogranulomatosis in residents of Foggy Albion.
An effective cure for deafness has been created
This type of blood cancer occurs when lymphocytes begin to multiply out of control, causing swelling in the lymph nodes in the neck, armpits and groin area. With the timely detection of the disease, patients are prescribed a specific cocktail of drugs for chemotherapy, which is effective in 90% of cases. But in about 40% of patients, lymphogranulomatosis is detected at a late stage with metastases to other parts of the body, including the lungs and liver.
Tests of a cure for lymphogranulomatosis are successful
One in three such patients die within 5 years after the diagnosis is made. Brentuximab vedotin, an antibody-drug conjugate, uses artificial proteins that deliver chemotherapy drugs directly to cancer cells. It is effective for patients who have gone through previous treatments but have relapsed as previously observed. And now it has been proven that out of 664 patients with lymphogranulomatosis at an advanced stage who received brentuximab, 625 saved their lives after 6 years. (READ MORE)